Novel signatures associated with systemic lupus erythematosus clinical response to IFN-alpha/-omega inhibition

CONCLUSIONS: These signatures may enable enrichment for treatment responders when using IFN-I-suppressing treatments in SLE.PMID:33626969 | DOI:10.1177/0961203321995576

Source: Lupus - February 25, 2021 Category: Rheumatology Authors: Loqmane Seridi Matteo Cesaroni Ashley Orillion Jessica Schreiter Marc Chevrier Stanley Marciniak Thi-Sau Migone William Stohl Walter Winn Chatham Richard Alan Furie Jacqueline Benson Jarrat Jordan Source Type: research